Ro. Brady et al., MODIFYING EXOGENOUS GLUCOCEREBROSIDASE FOR EFFECTIVE REPLACEMENT THERAPY IN GAUCHER DISEASE, Journal of inherited metabolic disease, 17(4), 1994, pp. 510-519
Important therapeutic principles were established in developing effect
ive enzyme replacement therapy for patients with Gaucher disease. The
background and sequence of the investigations that led to effective de
livery of exogenous glucocerebrosidase to the lipid-storing macrophage
s in patients with Guacher disease are described. The principle of tar
geting the intravenously injected enzyme to the mannose lectin on the
surface of these cells by engineering the glycoform of the enzyme is a
useful model of an essential requirement for effective enzyme therapy
. Similar strategies are expected to be effective for the treatment of
a number of hereditary metabolic disorders of humans.